London: Scientists have found a single class of drugs that can kill the parasites responsible for three tropical diseases that affect millions in Africa, Asia and Latin America - Chagas disease, leishmaniasis and sleeping sickness.
In a study published in the journal Nature, scientists at the Genomics Institute of the Novartis Research Foundation found the compound can cure all three diseases in mice, and does not harm normal human cells in laboratory tests.
This provides a strong starting point for developing new drugs to replace existing treatments that are expensive, sometimes not very effective, and can also have side effects.
Chagas, leishmaniasis and sleeping sickness kill more than 50,000 people a year, but receive relatively little funding for research and drug development.
They have different symptoms but are all caused by parasites called kinteoplastids with similar biology and genetics.
Hoping to find a shared weak spot in that biology, the scientists tested around 3 million chemicals on them. They identified a compound, called GNF6702, that worked against the parasites, and then refined it to make it more potent before testing in it mice.
"We found that these parasites harbor a common weakness. We hope to exploit this weakness to discover and develop a single class of drugs for all three diseases," said Frantisek Supek, who led the work.
The fact that GNF6702 seems to have no adverse effects in mice suggests it might have fewer side-effects than existing drugs, the researchers said, although this will need to be tested in human studies.
In a study published in the journal Nature, scientists at the Genomics Institute of the Novartis Research Foundation found the compound can cure all three diseases in mice, and does not harm normal human cells in laboratory tests.
This provides a strong starting point for developing new drugs to replace existing treatments that are expensive, sometimes not very effective, and can also have side effects.
They have different symptoms but are all caused by parasites called kinteoplastids with similar biology and genetics.
Advertisement
"We found that these parasites harbor a common weakness. We hope to exploit this weakness to discover and develop a single class of drugs for all three diseases," said Frantisek Supek, who led the work.
Advertisement
© Thomson Reuters 2016
COMMENTS
Advertisement
Scientists Develop Breakthrough Anti-Ageing Drug That Extends Lifespan by 25% India More Than Ready To Take Steps To Become Science Powerhouse: Nature Scientists Solve Mystery Behind What Makes Urine Yellow Mamata Banerjee To Take Out Rally Over Rape-Murder. Trinamool Explains Why Who Is Jasveen Sangha, "Ketamine Queen" Charged With Matthew Perry's Death "Don't Expect Anything From Me": Kolkata Hospital's New Principal Loses Cool Mamata Banerjee To Take Out Rally Over Rape-Murder. Trinamool Explains Why UPSC National Defence Academy 2 Admit Card to Be Released Soon UGC NET City Intimation Slips For August 27 Exam To Be Out Shortly Track Latest News Live on NDTV.com and get news updates from India and around the world.